Trade Humana - HUM CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
| Spread | 0.22 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Humana Inc ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
| Prev. Close* | 324.63 |
| Open* | 327.61 |
| 1-Year Change* | -36.03% |
| Day's Range* | 327.07 - 329.49 |
| 52 wk Range | 390.50-541.21 |
| Average Volume (10 days) | 2.45M |
| Average Volume (3 months) | 32.66M |
| Market Cap | 50.72B |
| P/E Ratio | 17.08 |
| Shares Outstanding | 123.11M |
| Revenue | 102.35B |
| EPS | 24.12 |
| Dividend (Yield %) | 0.85927 |
| Beta | 0.48 |
| Next Earnings Date | Jan 25, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 18, 2024 | 324.63 | 1.52 | 0.47% | 323.11 | 330.24 | 323.11 |
| Apr 17, 2024 | 323.09 | 4.43 | 1.39% | 318.66 | 323.96 | 318.04 |
| Apr 16, 2024 | 317.23 | -9.60 | -2.94% | 326.83 | 328.52 | 317.20 |
| Apr 15, 2024 | 314.33 | -0.62 | -0.20% | 314.95 | 317.42 | 311.74 |
| Apr 12, 2024 | 312.18 | -2.77 | -0.88% | 314.95 | 315.72 | 309.57 |
| Apr 11, 2024 | 316.06 | -2.28 | -0.72% | 318.34 | 320.06 | 315.08 |
| Apr 10, 2024 | 318.90 | 4.80 | 1.53% | 314.10 | 321.04 | 314.10 |
| Apr 9, 2024 | 319.24 | 5.24 | 1.67% | 314.00 | 319.48 | 313.95 |
| Apr 8, 2024 | 316.75 | 6.37 | 2.05% | 310.38 | 318.70 | 310.22 |
| Apr 5, 2024 | 312.73 | 7.50 | 2.46% | 305.23 | 314.06 | 305.22 |
| Apr 4, 2024 | 309.89 | 1.11 | 0.36% | 308.78 | 314.26 | 306.61 |
| Apr 3, 2024 | 308.00 | 3.10 | 1.02% | 304.90 | 312.54 | 301.76 |
| Apr 2, 2024 | 304.02 | -7.94 | -2.55% | 311.96 | 319.85 | 299.17 |
| Apr 1, 2024 | 351.21 | 5.26 | 1.52% | 345.95 | 352.83 | 345.27 |
| Mar 28, 2024 | 346.07 | -3.65 | -1.04% | 349.72 | 350.55 | 345.70 |
| Mar 27, 2024 | 349.23 | 0.79 | 0.23% | 348.44 | 350.94 | 347.25 |
| Mar 26, 2024 | 348.11 | 1.61 | 0.46% | 346.50 | 350.14 | 345.99 |
| Mar 25, 2024 | 346.84 | -2.12 | -0.61% | 348.96 | 349.14 | 345.42 |
| Mar 22, 2024 | 348.34 | 1.46 | 0.42% | 346.88 | 353.68 | 346.73 |
| Mar 21, 2024 | 347.33 | 2.22 | 0.64% | 345.11 | 351.81 | 344.86 |
Humana Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, April 24, 2024 | ||
| Time (UTC) 12:30 | Country US
| Event Q1 2024 Humana Inc Earnings Release Q1 2024 Humana Inc Earnings ReleaseForecast -Previous - |
| Time (UTC) 13:00 | Country US
| Event Q1 2024 Humana Inc Earnings Call Q1 2024 Humana Inc Earnings CallForecast -Previous - |
| Thursday, August 1, 2024 | ||
| Time (UTC) 13:00 | Country US
| Event Q2 2024 Humana Inc Earnings Call Q2 2024 Humana Inc Earnings CallForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 92870 | 83064 | 77155 | 64888 | 56912 |
| Total Operating Expense | 88833 | 79916 | 72169 | 61696 | 54598 |
| Depreciation / Amortization | 709 | 596 | 489 | 458 | 405 |
| Unusual Expense (Income) | 116 | 128 | 0 | 0 | 786 |
| Other Operating Expenses, Total | 12318 | 9993 | 10052 | 7145 | 7525 |
| Operating Income | 4037 | 3148 | 4986 | 3192 | 2314 |
| Interest Income (Expense), Net Non-Operating | -401 | -326 | -283 | -242 | -218 |
| Net Income Before Taxes | 3568 | 3354 | 4600 | 3456 | 2063 |
| Net Income After Taxes | 2806 | 2869 | 3293 | 2693 | 1711 |
| Net Income Before Extra. Items | 2806 | 2933 | 3367 | 2707 | 1722 |
| Net Income | 2806 | 2933 | 3367 | 2707 | 1683 |
| Income Available to Common Excl. Extra. Items | 2806 | 2933 | 3367 | 2707 | 1722 |
| Income Available to Common Incl. Extra. Items | 2806 | 2933 | 3367 | 2707 | 1683 |
| Diluted Net Income | 2806 | 2933 | 3367 | 2707 | 1683 |
| Diluted Weighted Average Shares | 127.094 | 129.396 | 133.012 | 134.727 | 138.403 |
| Diluted EPS Excluding Extraordinary Items | 22.0781 | 22.6668 | 25.3135 | 20.0925 | 12.4419 |
| Dividends per Share - Common Stock Primary Issue | 3.15 | 2.8 | 3.05 | 2.15 | 1.9 |
| Diluted Normalized EPS | 22.7959 | 23.513 | 25.3135 | 20.0925 | 17.152 |
| Total Premiums Earned | 92488 | 82877 | 76001 | 64387 | 56398 |
| Net Investment Income | 382 | 187 | 1154 | 501 | 514 |
| Losses, Benefits, and Adjustments, Total | 75690 | 69199 | 61628 | 53857 | 45882 |
| Total Extraordinary Items | 0 | -39 | |||
| Other, Net | -68 | 532 | -103 | 506 | -33 |
| Equity In Affiliates | -4 | 65 | 74 | 14 | 11 |
| Selling/General/Admin. Expenses, Total | 236 | ||||
| Minority Interest | 4 | -1 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 26747 | 26742 | 22439 | 22799 | 23662 |
| Total Operating Expense | 25311 | 25023 | 22318 | 21387 | 22447 |
| Depreciation / Amortization | 191 | 186 | 182 | 182 | 175 |
| Other Operating Expenses, Total | 3107 | 3030 | 3412 | 3040 | 2997 |
| Operating Income | 1436 | 1719 | 121 | 1412 | 1215 |
| Interest Income (Expense), Net Non-Operating | -120 | -113 | -108 | -102 | -101 |
| Other, Net | -54 | 8 | -84 | -13 | 8 |
| Net Income Before Taxes | 1262 | 1614 | -71 | 1297 | 1122 |
| Net Income After Taxes | 966 | 1255 | -13 | 1190 | 695 |
| Equity In Affiliates | -10 | -17 | -5 | 3 | 2 |
| Net Income Before Extra. Items | 959 | 1239 | -15 | 1195 | 696 |
| Net Income | 959 | 1239 | -15 | 1195 | 696 |
| Income Available to Common Excl. Extra. Items | 959 | 1239 | -15 | 1195 | 696 |
| Income Available to Common Incl. Extra. Items | 959 | 1239 | -15 | 1195 | 696 |
| Diluted Net Income | 959 | 1239 | -15 | 1195 | 696 |
| Diluted Weighted Average Shares | 125.109 | 125.564 | 125.642 | 127.356 | 127.084 |
| Diluted EPS Excluding Extraordinary Items | 7.66532 | 9.86748 | -0.11939 | 9.38315 | 5.47669 |
| Dividends per Share - Common Stock Primary Issue | 0.885 | 0.885 | 0.7875 | 0.7875 | 0.7875 |
| Diluted Normalized EPS | 7.68979 | 9.55165 | 0.61524 | 7.80542 | 6.33455 |
| Total Premiums Earned | 26473 | 26549 | 22279 | 22627 | 23615 |
| Net Investment Income | 274 | 193 | 160 | 172 | 47 |
| Losses, Benefits, and Adjustments, Total | 22009 | 21858 | 18582 | 18384 | 19099 |
| Unusual Expense (Income) | 4 | -51 | 142 | -219 | 176 |
| Minority Interest | 3 | 1 | 3 | 2 | -1 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 5061 | 3394 | 4673 | 4054 | 2343 |
| Total Assets | 43055 | 44358 | 34969 | 29074 | 25413 |
| Property/Plant/Equipment, Total - Net | 3736 | 3751 | 2808 | 2365 | 1735 |
| Property/Plant/Equipment, Total - Gross | 6872 | 6625 | 5931 | 5025 | 4048 |
| Accumulated Depreciation, Total | -3136 | -2874 | -3123 | -2660 | -2313 |
| Goodwill, Net | 9142 | 11092 | 4447 | 3928 | 3897 |
| Intangibles, Net | 1765 | 2639 | 329 | 177 | 245 |
| Long Term Investments | 15010 | 14113 | 14936 | 12441 | 11484 |
| Other Assets, Total | 6667 | 7555 | 6638 | 5053 | 4694 |
| Payable/Accrued | 5086 | 4324 | 3884 | 3638 | 3067 |
| Notes Payable/Short Term Debt | 893 | 326 | 320 | 525 | 1466 |
| Current Port. of LT Debt/Capital Leases | 1497 | 1953 | 600 | 399 | 399 |
| Other Current Liabilities, Total | 286 | 254 | 318 | 247 | 283 |
| Total Liabilities | 27744 | 28278 | 21241 | 17037 | 15252 |
| Total Long Term Debt | 9034 | 10541 | 6060 | 4967 | 4375 |
| Long Term Debt | 9034 | 10541 | 6060 | 4967 | 4375 |
| Other Liabilities, Total | 1017 | 1837 | 1432 | 809 | 800 |
| Total Equity | 15311 | 16080 | 13728 | 12037 | 10161 |
| Common Stock | 33 | 33 | 33 | 33 | 33 |
| Additional Paid-In Capital | 3246 | 3082 | 2705 | 2820 | 2535 |
| Retained Earnings (Accumulated Deficit) | 25492 | 23086 | 20517 | 17483 | 15072 |
| Treasury Stock - Common | -12156 | -10163 | -9918 | -8455 | -7320 |
| Other Equity, Total | -1304 | 42 | 391 | 156 | -159 |
| Total Liabilities & Shareholders’ Equity | 43055 | 44358 | 34969 | 29074 | 25413 |
| Total Common Shares Outstanding | 124.975 | 128.802 | 128.861 | 132.105 | 135.567 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 608 | 731 | 484 | 448 | |
| Minority Interest | 59 | 23 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 15148 | 16214 | 13735 | 5061 | 13558 |
| Total Assets | 55905 | 56455 | 54776 | 43055 | 50765 |
| Property/Plant/Equipment, Total - Net | 3342 | 3309 | 3234 | 3221 | 3218 |
| Goodwill, Net | 9540 | 9539 | 9320 | 9142 | 9096 |
| Intangibles, Net | 1765 | 1782 | 1754 | 1765 | 1797 |
| Long Term Investments | 16277 | 16373 | 16042 | 15010 | 14237 |
| Other Assets, Total | 8009 | 7809 | 7584 | 7182 | 7250 |
| Payable/Accrued | 7600 | 8118 | 7431 | 5238 | 6766 |
| Notes Payable/Short Term Debt | 2491 | 1304 | 832 | 893 | 540 |
| Other Current Liabilities, Total | 7536 | 7378 | 7220 | 286 | 6012 |
| Total Liabilities | 38956 | 39621 | 38199 | 27744 | 34511 |
| Total Long Term Debt | 9483 | 9722 | 9743 | 9034 | 7798 |
| Long Term Debt | 9483 | 9722 | 9743 | 9034 | 7798 |
| Other Liabilities, Total | 1595 | 1563 | 1457 | 1473 | 1599 |
| Total Equity | 16949 | 16834 | 16577 | 15311 | 16254 |
| Common Stock | 33 | 33 | 33 | 33 | 33 |
| Additional Paid-In Capital | 3362 | 3313 | 3262 | 3246 | 3234 |
| Retained Earnings (Accumulated Deficit) | 28191 | 27468 | 26619 | 25492 | 25606 |
| Treasury Stock - Common | -13134 | -12754 | -12224 | -12156 | -11152 |
| Other Equity, Total | -1503 | -1226 | -1113 | -1304 | -1467 |
| Total Liabilities & Shareholders’ Equity | 55905 | 56455 | 54776 | 43055 | 50765 |
| Total Common Shares Outstanding | 123.111 | 123.907 | 124.945 | 124.975 | 126.6 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 1175 | 1441 | 1497 | 2496 |
| Minority Interest | 55 | 57 | 57 | 59 | 63 |
| Other Long Term Assets, Total |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 2802 | 2934 | 3367 | 2707 | 1683 |
| Cash From Operating Activities | 4587 | 2262 | 5639 | 5284 | 2173 |
| Cash From Operating Activities | 749 | 640 | 528 | 505 | 444 |
| Amortization | 96 | 73 | 88 | 70 | 90 |
| Deferred Taxes | -100 | 15 | 195 | 162 | 194 |
| Non-Cash Items | 231 | -1014 | 107 | 149 | 948 |
| Cash Taxes Paid | 758 | 227 | 1132 | 518 | 631 |
| Cash Interest Paid | 354 | 285 | 258 | 212 | 195 |
| Changes in Working Capital | 809 | -386 | 1354 | 1691 | -1186 |
| Cash From Investing Activities | -1006 | -6556 | -3065 | -1278 | -3087 |
| Capital Expenditures | -1120 | -1316 | -964 | -736 | -612 |
| Other Investing Cash Flow Items, Total | 114 | -5240 | -2101 | -542 | -2475 |
| Cash From Financing Activities | -1914 | 3015 | -1955 | -2295 | -785 |
| Financing Cash Flow Items | 1987 | -337 | -939 | -623 | -640 |
| Total Cash Dividends Paid | -392 | -354 | -323 | -291 | -265 |
| Issuance (Retirement) of Stock, Net | -2087 | -58 | -1771 | -1012 | -1045 |
| Issuance (Retirement) of Debt, Net | -1422 | 3764 | 1078 | -369 | 1165 |
| Net Change in Cash | 1667 | -1279 | 619 | 1711 | -1699 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1238 | 2802 | 2820 | 1627 | 930 |
| Cash From Operating Activities | 6687 | 4587 | 9714 | 1261 | 302 |
| Cash From Operating Activities | 200 | 749 | 555 | 369 | 181 |
| Amortization | 18 | 96 | 73 | 45 | 24 |
| Non-Cash Items | 55 | 231 | 76 | 235 | 47 |
| Cash Taxes Paid | 6 | 758 | 751 | 373 | -20 |
| Cash Interest Paid | 97 | 354 | 256 | 171 | 67 |
| Changes in Working Capital | 5176 | 809 | 6223 | -1182 | -880 |
| Cash From Investing Activities | -1292 | -1006 | 6 | -1670 | -648 |
| Capital Expenditures | -223 | -1120 | -862 | -574 | -295 |
| Other Investing Cash Flow Items, Total | -1069 | 114 | 868 | -1096 | -353 |
| Cash From Financing Activities | 3279 | -1914 | 444 | 2235 | 1816 |
| Financing Cash Flow Items | 2887 | 1987 | 3785 | 3074 | 2474 |
| Total Cash Dividends Paid | -100 | -392 | -291 | -191 | -91 |
| Issuance (Retirement) of Stock, Net | -94 | -2087 | -1045 | -1039 | -1037 |
| Issuance (Retirement) of Debt, Net | 586 | -1422 | -2005 | 391 | 470 |
| Net Change in Cash | 8674 | 1667 | 10164 | 1826 | 1470 |
| Deferred Taxes | -100 | -33 | 167 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Humana Company profile
About Humana Inc
Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Humana Inc revenues increased 8% to $83.06B. Net income decreased 13% to $2.93B. Revenues reflect Retail segment increase of 10% to $73.84B, Healthcare Services segment increase from $1.02B to $2.22B, Medical Expense Ratio -%-Employer Group decrease of 4% to 82.5%. Net income was offset by Eliminations/Corporate segment loss totaling $202M vs. income of $1.24B.
Equity composition
Common Stock $.16 2/3 Par, 3/11, 300M auth., 191,607,107 issd., less 23,212,730 shs. in Treas. @ $583.3M. Insiders owns approx. 0.57%. PO11/82, 3M shares @ $13.125 by Lehman Brothers Kuhn Loeb. *NOTE: 3/93, the acute care hospital division (Galen Health Care) was spun off. FY'99-'00 and FY'00-'01 Q's are reclassified.
| Industry: | Managed Healthcare (NEC) |
500 W Main St
LOUISVILLE
KENTUCKY 40202
US
Income Statement
- Annual
- Quarterly
News
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024
Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com